Feb 25, 2021 / 09:30PM GMT
Operator
Greetings, and welcome to Ziopharm Oncology, Inc. Fourth Quarter and Fiscal Year 2020 Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.
I would now like to turn the conference over to your host, Adam Levy, Executive Vice President of Investor Relations and Corporate Communications. Please go ahead.
Adam D. Levy - ZIOPHARM Oncology, Inc. - EVP of IR & Corporate Communications
Thank you, Omar. Good afternoon, and welcome to the Ziopharm Oncology Conference call and webcast to review results for the fourth quarter and year ended December 31, 2020. This afternoon, we issued our financial press release, which is also available in the Investors section of our website, ziopharm.com.
For informational purposes, we have also included in our webcast a set of slides to accompany today's commentary. These slides can also be found on our website. Today's press release also contains several other corporate updates which will be discussed by our speakers.
During today's call, the company will
Q4 2020 ZIOPHARM Oncology Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
